Know Labs, Inc. Under Scrutiny from NYSE American
Recently, NYSE American LLC has made a significant announcement regarding Know Labs, Inc. (ticker: KNW). The staff of NYSE Regulation has initiated proceedings to delist the common stock of the company from their exchange. This decision comes as a result of concerns regarding the low selling price of the company's common stock, leading to an immediate suspension of trading.
Reason Behind the Delisting
NYSE Regulation has stated that Know Labs, Inc. does not currently meet the listing standards as outlined in Section 1003(f)(v) of its Company Guide. This section relates to the financial health and market conditions that a company must maintain to remain listed on the NYSE American.
Next Steps for Know Labs, Inc.
The company will now have the opportunity to appeal the staff's determination to a panel that oversees listing qualifications. This panel is responsible for assessing the evidential grounds for delisting and whether the company can rectify its situation. Know Labs, Inc. is entitled to argue its case for maintaining its status on the exchange.
Impact on Investors and Future Trading
For current investors in Know Labs, Inc., this news raises a series of questions regarding the future viability of their investments. As trading has ceased, shareholders will be monitoring any developments closely, especially concerning the company's potential appeal against the delisting. Following through with the recommended procedures will be crucial for the company’s market presence.
Conclusion
In summary, the events surrounding Know Labs, Inc. and the NYSE American serve as a notable reminder of the rigorous standards required for public companies. Maintaining these standards is essential for the trust and confidence of investors. As the situation develops, interested parties should stay informed on updates directly from the company and regulatory bodies.
Frequently Asked Questions
What led to the delisting of Know Labs, Inc.?
The delisting was prompted by concerns over the low selling price of the company's common stock, which did not meet the exchange's listing standards.
Can Know Labs, Inc. appeal the delisting decision?
Yes, Know Labs, Inc. has the right to appeal the determination made by the NYSE Regulation staff to a review panel.
What should investors do during this period?
Investors should stay updated and monitor any announcements from Know Labs, Inc. regarding the appeal and the overall situation.
How long does the appeal process take?
The duration of the appeal process can vary, depending on the complexity of the case and the timelines set by the NYSE American.
What are the implications of a successful appeal?
If successful, the appeal could allow Know Labs, Inc. to regain its listing on the NYSE American, restoring trading of its common stock.
